Swipe for more

• October 15, 2024

  bioMérieux receives CE-marking for VIDAS® VITAMIN B12 TOTAL, a blood test to measure total Vitamin B12 concentration

  bioMérieux, a world leader in the field of in vitro diagnostics, announces the CE-marking of VIDAS® VITAMIN B12 TOTAL, an automated quantitative test for use on the VIDAS® immunoassay instruments, for the measurement of total Vitamin B12 concentration in human serum or plasma.

  Read more
  

• July 30, 2024

  bioMérieux Receives 10 Clinical Laboratory Awards for Excellence in Customer Satisfaction, System Performance and Service

  bioMérieux, a world leader in in vitro diagnostics, received 10 IMV ServiceTrak™ Clinical Laboratory Awards today in the categories of microbial identification and susceptibility testing, Blood Culture, Immunoassay, and Molecular Diagnostics. The awards symbolize bioMérieux’s high-quality comprehensive customer service and system performance.

  Read more
  

• June 26, 2024

  bioMérieux receives U.S. FDA Special 510(k) clearance and CLIA-waiver for its BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel Mini

  bioMérieux, a world leader in the field of in vitro diagnostics, today announces that its BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel Mini has received U.S. Food and Drug Administration (FDA) Special 510(k) clearance and CLIA-waiver (Clinical Laboratory Improvement Amendments).

  Read more